This inhibition leads to the downregulation of T-cell-specific transcription factor 1 (TCF-1), Runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP), and osteopontin (OPN), which are downstream osteogenic markers, thereby promoting osteoporosis [18]. This evidence concerns the gene SPP1 and osteoporosis.